glp-1 receptor agonist examples Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Unlocking the broad health benefits

If you buy through our links, the USA TODAY Network may earn a commission

Many recent studies also focus on the metabolic aspects of depression, suggesting the involvement of peripheral and central impairments in energy homeostasis, mitochondrial dysfunction, as well as disturbances in the gut-brain axis and gut microbiota dysbiosis as noteworthy factors in the pathogenesis of depression [6,7,8,9]

By enhancing feelings of fullness, slowing stomach emptying, and supporting healthy insulin response, GLP-1 medications help you eat less and better control your weight and blood sugar

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week, open-label, phase IV study

Evidence on benefits beyond two years was more limited